Department of Pharmacology and Toxicology, Pharmacy College, King Saud University, Saudi Arabia; Prince Naïf Bin Abdul-Aziz Health Research Center, King Saud University, Saudi Arabia.
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 8;105:110120. doi: 10.1016/j.pnpbp.2020.110120. Epub 2020 Sep 28.
Although there is a sex bias in the pathological mechanisms exhibited by brain disorders, investigation of the female brain in biomedical science has long been neglected. Use of the male model has generally been the preferred option as the female animal model exhibits both biological variability and hormonal fluctuations. Existing studies that compare behavioral and/or molecular alterations in animal models of brain diseases are generally underrepresented, and most utilize the male model. Nevertheless, in recent years there has been a trend toward the increased inclusion of females in brain studies. However, current knowledge regarding sex-based differences in depression and stress-related disorders is limited. This can be improved by reviewing preclinical studies that highlight sex differences in depression. This paper therefore presents a review of sex-based preclinical studies of depression. These shed light on the discrepancies between males and females regarding the biological mechanisms that underpin mechanistic alterations in the diseased brain. This review also highlights the conclusions drawn by preclinical studies to advance our understanding of mood disorders, encouraging researchers to promote ways of investigating and managing sexually dimorphic disorders.
尽管脑疾病表现出的病理机制存在性别偏向,但长期以来,生物医学科学一直忽视对女性大脑的研究。由于雌性动物模型具有生物学变异性和激素波动,因此通常优先使用雄性模型。现有的比较脑疾病动物模型中行为和/或分子变化的研究普遍代表性不足,且大多数都使用雄性模型。然而,近年来,在大脑研究中纳入女性的趋势有所增加。但是,目前关于抑郁和应激相关障碍中基于性别的差异的知识有限。通过回顾强调抑郁中性别差异的临床前研究,可以对此加以改善。因此,本文对基于性别的抑郁临床前研究进行了综述。这些研究揭示了男性和女性在潜在疾病大脑的机制改变方面的生物学机制存在差异。这篇综述还强调了临床前研究得出的结论,以促进我们对情绪障碍的理解,鼓励研究人员寻找调查和管理性别二态性疾病的方法。